The news of former President Biden's prostate cancer has reignited the debate over PSA screening's balance between benefits and harms. Experts highlight that while PSA tests can detect cancer, they often lead to overtreatment of non-threatening cases, causing significant side effects. Studies show many older men have prostate cancer that poses little risk. Thus, the focus remains on accurately identifying aggressive cancers while avoiding unnecessary interventions for indolent cases. There’s currently no effective test for prostate cancer other than PSA screening, which has been in use since the 1990s.
PSA testing alone leaves a lot to be desired as a cancer screening test.
PSA screening is beneficial, but there are risks, making it a personal decision whether to proceed with it.
Collection
[
|
...
]